Understanding Allergra
Allergra 120mg by Aventis is a pharmaceutical-grade antihistamine preparation containing fexofenadine hydrochloride as the active component. Fexofenadine is a non-sedating H1 antihistamine receptor antagonist that represents the active metabolite of terfenadine. This compound demonstrates high selectivity for peripheral H1 receptors while exhibiting minimal penetration across the blood-brain barrier in preclinical models. Researchers at Stroid UK Shop frequently investigate fexofenadine’s mechanisms in histamine-mediated inflammatory pathways and immunological response modulation studies.
Laboratory Applications
In research environments, fexofenadine serves as a valuable tool for examining antihistaminic activity and inflammatory cascade interruption. Scientists study its competitive antagonism at H1 receptors and subsequent effects on vasodilation, increased vascular permeability, and smooth muscle contraction responses. The compound’s non-sedating profile makes it particularly useful for comparative studies with first-generation antihistamines. Research teams examining fexofenadine and related compounds often evaluate its pharmacokinetic properties, including rapid oral absorption and minimal hepatic metabolism. Additionally, fexofenadine research extends to investigations of mast cell degranulation inhibition and cytokine release modulation in cellular models. Laboratories studying alongside selective androgen receptor modulators and research peptides utilize fexofenadine as a control compound in multi-pathway inflammatory studies.
Technical Specifications
| Active Ingredient | Fexofenadine Hydrochloride |
|---|---|
| Strength | 120mg per tablet |
| Manufacturer | Aventis |
| CAS Number | 153439-40-8 |
| Molecular Formula | C₃₂H₃₉NO₄·HCl |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance
This product is supplied strictly for in-vitro laboratory research purposes only. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate handling protocols and institutional approval before conducting studies.
